Clinical usefulness of plasma 1,5-anhydroglucitol, fructosamine and blood HbAlc level in mice with abnormal glucose metabolism and in controls

被引:0
|
作者
Tabata H. [1 ,3 ]
Kubo M. [2 ]
Suzuki H. [1 ]
Matsuzawa T. [2 ]
Kariya K. [1 ]
机构
[1] Yamanouchi Pharmaceutical Co. Ltd, Tokyo
[2] Faculty of Pharmaceutical Sciences, Kobegakuin University, Nishi-ku, Kobe
[3] Safety Research Laboratories, Yamanouchi Pharmaceutical Co. Ltd., Itabashi-ku, Tokyo 174-8511
来源
关键词
1,5-anhydroglucitol; Blood glucose; Fructosamine; Glycaemic marker; Haemoglobin alc; Mice;
D O I
10.1007/BF02585515
中图分类号
学科分类号
摘要
We compared the usefulness of blood measurements of 1,5-anhydroglucitol (1,5-AG), fructosamine and blood haemoglobin Alc (HbA|C) levels in C57BL/KsJ mice with abnormal glucose metabolism and in controls. Both streptozotocin (STZ)-induced diabetic mice (db/m genotype) and genetically diabetic mice (db/ db genotype) displaying a hyperglycaemia, plasma 1,5AG level fell rapidly and dramatically. In contrast, both fructosamine and HbAlc increased so gradually that they provided an approximation of glycaemic conditions over a few weeks. Food-restricted mice displayed a slight hypoglycaemia, with fructosamine and HbAic level reducing slightly but significantly at 4 and 12 weeks, respectively after commencement of treatment. These three glycaemic parameters were significantly correlated with blood glucose, suggesting that these three glycaemic parameters are specifically related to the abnormal glucose metabolism, and that their routine examination in mice may help delineate the metabolic derangement in the disease or provide analytical information in preclinical studies. © 1999 Springer-Verlag London Limited.
引用
收藏
页码:7 / 12
页数:5
相关论文
共 30 条
  • [21] 1,5-anhydroglucitol and postprandial hyperglycemia as assessed by self-monitoring of blood glucose in Japanese patients with moderately controlled diabetes
    Akutsu, Toshie
    Mori, Yutaka
    Itoh, Yohta
    Tajima, Naoko
    DIABETES, 2007, 56 : A112 - A113
  • [22] Model analysis of effect of canagliflozin (Invokana), a sodium-glucose cotransporter 2 inhibitor, to alter plasma 1,5-anhydroglucitol
    Fortuna, Danielle
    McCloskey, Laura J.
    Stickle, Douglas F.
    CLINICA CHIMICA ACTA, 2016, 452 : 138 - 141
  • [23] Combining serum 1,5-anhydroglucitol with fasting plasma glucose to detect diabetes mellitus in a community-based population with hypertension
    Yuan, Yuexing
    Cheng, Jinfeng
    Chen, Cheng
    Wang, Yao
    ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (08) : 8746 - 8752
  • [24] Associations of 1,5-Anhydroglucitol and 2-Hour Glucose with Major Clinical Outcomes in the Atherosclerosis Risk in Communities (ARIC) Study
    Warren, Bethany
    Lee, Alexandra K.
    Ballantyne, Christie M.
    Hoogeveen, Ron C.
    Pankow, James S.
    Grams, Morgan E.
    Kottgen, Anna
    Selvin, Elizabeth
    JOURNAL OF APPLIED LABORATORY MEDICINE, 2020, 5 (06): : 1296 - 1306
  • [25] Mannose, mannitol, fructose and 1,5-anhydroglucitol concentrations measured by gas chromatography mass spectrometry in blood plasma of diabetic patients
    Pitkanen, E
    CLINICA CHIMICA ACTA, 1996, 251 (01) : 91 - 103
  • [26] Racial and Ethnic Differences in Mean Plasma Glucose, Hemoglobin A1c, and 1,5-Anhydroglucitol in Over 2000 Patients with Type 2 Diabetes
    Herman, William H.
    Dungan, Kathleen M.
    Wolffenbuttel, Bruce H. R.
    Buse, John B.
    Fahrbach, Jessie L.
    Jiang, Honghua
    Martin, Sherry
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (05): : 1689 - 1694
  • [27] Evaluation of Relationship between Postprandial Glucose Level and Progression of Atherosclerosis in Normal Glucose-Tolerant Patients with Hypertension or Dyslipidemia by Using Carotid Ultrasound Variables and Serum 1,5-Anhydroglucitol (1,5-AG)
    Watanabe, Kentaro
    Suzuki, Kazunari
    Sekimizu, Kenichi
    Suzuki, Tatsuya
    Nakano, Hiroshi
    Oba, Kenzo
    DIABETES, 2010, 59 : A230 - A230
  • [28] Association of Alternative Markers of Carbohydrate Metabolism (Fructosamine and 1,5-Anhydroglucitol) with Perioperative Characteristics and In-Hospital Complications of Coronary Artery Bypass Grafting in Patients with Type 2 Diabetes Mellitus, Prediabetes, and Normoglycemia
    Sumin, Alexey N.
    Bezdenezhnykh, Natalia A.
    Bezdenezhnykh, Andrey V.
    Kuzmina, Anastasiya A.
    Dyleva, Yuliya A.
    Barbarash, Olga L.
    DIAGNOSTICS, 2023, 13 (05)
  • [29] Association of 1,5-anhydroglucitol and 2-h postprandial blood glucose in type 2 diabetic patients: response to Stettler et al. (vol 31, pg e389, 2008)
    Schindhelm, R. K.
    Diamant, M.
    Bilo, H. J.
    Slingerland, R. J.
    DIABETES CARE, 2009, 32 (01) : 207 - 207
  • [30] BLOOD LEVEL, EXCRETION, DISTRIBUTION AND METABOLISM OF C-14-TRIFLUBAZAM, A NEW 1,5-BENZODIAZEPINE, IN MICE AND DOGS
    BECHTEL, WD
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1974, 282 : R6 - R6